# Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)

> **NCT04762771** · PHASE1,PHASE2 · TERMINATED · sponsor: **Baptist Health South Florida** · enrollment: 2 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Colchicine

## Key facts

- **NCT ID:** NCT04762771
- **Lead sponsor:** Baptist Health South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-23
- **Primary completion:** 2021-05-12
- **Final completion:** 2021-09-20
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Recovery Trial showed no convincing evidence that further recruitment would provide conclusive proof of worthwhile benefit for the evaluation of Colchicine in patients with Covid-19.
- **Last updated:** 2022-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04762771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04762771, "Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04762771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*